Diabetes Research Centers (P30 Clinical Trial Optional)
Funding Opportunity RFA-DK-25-008 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications for Diabetes Research Centers (DRCs) that are designed to support and enhance the national research effort in diabetes, its complications, and related endocrine and metabolic diseases. The purpose of this Centers program is to bring together basic and clinical investigators to enhance communication, multidisciplinary collaboration, and effectiveness of ongoing research in Diabetes Research Center topic areas. By providing shared access to specialized technical resources (research ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 1, 2024 Category: Research Source Type: funding
Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-23-007 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) requests applications to explore human pancreatic tissues and the immune compartment for the discovery of specific signaling or processing pathways that may contribute to the asymptomatic phase of T1D, the discovery of early biomarkers of T1D pathogenesis, the development of diagnostic tools for the detection and staging of early T1D in at-risk or recently-diagnosed individuals, and/or the identification and biological validation of therapeutic targets for the development of preventative or early trea...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 1, 2024 Category: Research Source Type: funding
Notice of Update to National Institute of Diabetes and Digestive and Kidney Disease Central Repository (NIDDK-CR) Cost Recovery Policy
Notice NOT-DK-24-011 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 1, 2024 Category: Research Source Type: funding
Adaptation of Diabetes Control Technologies for Older Adults with T1D (R01 Clinical Trial Optional)
Funding Opportunity RFA-DK-24-002 from the NIH Guide for Grants and Contracts. The main objective of this NOFO is to foster development and testing of technologies adaptable to aging-related changes in older adults (aged 65 years or older) with T1D to improve diabetes management and quality of life. Older adults may have increased vulnerability to hypoglycemia, cognitive impairment and/or multiple co-morbidities which may affect the risks and benefits of these technologies in this population. Projects will be funded to a) develop and test new technologies and b) to adapt and test existing technologies. It is expected th...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 1, 2024 Category: Research Source Type: funding
Request for Information (RFI): Inviting Comments and Feedback on the National Institute of Diabetes and Digestive and Kidney Disease, Division of Kidney, Urologic, and Hematologic Diseases Institutional Network Award (U2C-TL1)
Notice NOT-DK-24-018 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 19, 2024 Category: Research Source Type: funding
Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Disparities Among Women and Girls in Racial/Ethnic Minority and Other Underserved Communities (U34 Clinical Trials Required)
Funding Opportunity RFA-AA-24-006 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support the planning phase of the Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Disparities Among Women and Girls in Racial/Ethnic Minority and Other Underserved Communities. MCCI is a multi-ICO dissemination and implementation science initiative to advance health equity and end health disparities in racial/ethnic minority women and girls of reproductive age. Specifically, the Model Continuums of Care Initiative will apply the latest dissemination and implementationscience app...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 6, 2024 Category: Research Source Type: funding
Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
Funding Opportunity PAS-24-163 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) seeks to stimulate HIV/AIDS research within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) that align with the HIV/AIDS research priorities outlined by the NIH Office of AIDS Research (OAR). These priorities were most recently described in NOT-OD-20-018 UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 29, 2024 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Administrative Supplements to Enhance Engagement Activity with Underserved Populations Within the Type 1 Diabetes Community (Admin Supp Clinical Trial Not Allowed)
Notice NOT-DK-24-010 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 16, 2024 Category: Research Source Type: funding
Continuous Ketone Monitoring for the Safe Use of Sodium-glucose Cotransporter-2 Inhibitors in Type 1 Diabetes (R01 Clinical trial Required)
Funding Opportunity RFA-DK-23-011 from the NIH Guide for Grants and Contracts. Sodium-glucose co-transporter-2 inhibitors (SGLT2i) that were developed for the treatment of type 2 diabetes (T2D) have significant protective effects for cardiac and renal diseases for people with and without diabetes. However, SGLT2i are not currently approved for individuals with type 1 diabetes (T1D) and there is an increased risk of diabetic ketoacidosis (DKA) for this population. Despite this concern, these drugs are increasingly being prescribed off-label for people with T1D. Continuous ketone monitoring (CKM) is a rapidly evolving tec...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 30, 2024 Category: Research Source Type: funding
Notice of Intent to Publish a Notice of Funding Opportunity for Diabetes Research Centers (P30 Clinical Trial Optional)
Notice NOT-DK-24-009 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 24, 2024 Category: Research Source Type: funding
NIDDK Education Program Grants (R25 Clinical Trial Not Allowed)
Funding Opportunity PAR-24-074 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this NOFO will support educational activities with a primary focus on: Courses for Skills Development Research Experiences These courses for skill development and research experiences m...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 21, 2023 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required)
Notice NOT-DK-24-004 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 18, 2023 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for Type 1 Diabetes TrialNet Clinical Network Hub (U01 Clinical Trial Not Allowed)
Notice NOT-DK-24-005 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 18, 2023 Category: Research Source Type: funding
Going For Gold and Beyond in the Rural Midwest: Grant for Health Care Organizations
Grants for rural healthcare organizations in the Midwest to lead evidence-based policy and practice changes in the areas of blood pressure, cholesterol, and type 2 diabetes. Geographic coverage: The Midwest region of the American Heart Association -- American Heart Association (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - December 16, 2023 Category: American Health Source Type: funding
Cardiovascular Repository Type 1 Diabetes (CARE-T1D) Consortium (U01 Clinical Trial Not Allowed).
Funding Opportunity RFA-DK-23-021 from the NIH Guide for Grants and Contracts. Cardiovascular complications are the leading cause of death for individuals with type 1 diabetes (T1D) and significantly shorten their lives. Cardiovascular disease (CVD) progression in people with T1D differs from that observed in people with type 2 diabetes (T2D) and residual increased risk of CVD remains after treatment of standard risk factors, such as hyperglycemia, hypertension, and hyperlipidemia. The NIH Cardiovascular Repository for T1D (CaRe-T1D) was initiated with the goal of establishing a biorepository of human CV tissue and a sc...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 30, 2023 Category: Research Source Type: funding
